Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer
Clinical trial NCT01301911 · TERMINATED
Trial details
- NCT number
- NCT01301911
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.